国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水

Guideview > Regeneron

Regeneron Secures $2B Deal for Hansoh’s Obesity Drug Rivaling Zepbound Regeneron Regeneron signs a $2B deal with Hansoh Pharma for HS-20094, a GLP-1/GIP receptor agonist aimed at rivaling Eli Lilly’s Zepbound in the obesity market. The deal boosts Regeneron's obesity pipeline with late-stage drug access and new combo therapy potential.
Pharma's $158B U.S. Manufacturing Surge Market Trend Major pharmaceutical companies pledge $158 billion to U.S. manufacturing to sidestep tariff threats, funding facilities from California to North Carolina. Lilly, J&J, Novartis, Roche and Regeneron drive billions in reshoring investments, creating thousands of jobs.

Articles Archives

Hot Articles

All Categories